PBI’s expertise lies at the intersection of the Cardio-Renal and Cardio-Pulmonary axes. Studying these interdependent organ systems in the context of inflammatory and fibrotic insults – such as diabetes, chronic kidney disease or idiopathic pulmonary fibrosis – provides a comprehensive view of drug candidate effects on disease processes.

Using well-defined model systems and with the expertise to evaluate multiple organ systems simultaneously, we offer superior drug discovery research comprised of: